Hologic (NASDAQ:HOLX) Upgraded to “Buy” by BidaskClub
Several other brokerages also recently commented on HOLX. Zacks Investment Research raised shares of Hudson Technologies from a sell rating to a hold rating in a research note on Wednesday, May 29th. BTIG Research raised their price target on shares of Yum! Brands to $114.00 and gave the company a buy rating in a research note on Thursday, May 2nd. TheStreet downgraded shares of ZTO Express (Cayman) from a b+ rating to a c rating in a research note on Wednesday, May 1st. Needham & Company LLC dropped their price target on shares of to $10.00 and set a buy rating for the company in a research note on Wednesday, July 10th. Finally, ValuEngine raised shares of China Southern Airlines from a sell rating to a hold rating in a research note on Tuesday, June 11th. One investment analyst has rated the stock with a sell rating, seven have issued a hold rating and seven have issued a buy rating to the company. Hologic has an average rating of Hold and an average price target of $45.02.
NASDAQ:HOLX traded up $0.13 on Friday, hitting $49.49. The company had a trading volume of 1,068,613 shares, compared to its average volume of 1,984,292. The stock has a market cap of $13.27 billion, a PE ratio of 22.19, a price-to-earnings-growth ratio of 2.29 and a beta of 0.72. The company has a quick ratio of 1.02, a current ratio of 1.45 and a debt-to-equity ratio of 1.31. The company’s 50 day moving average price is $48.05. Hologic has a 52 week low of $37.47 and a 52 week high of $49.78.
In other news, insider Peter J. Valenti III sold 4,545 shares of the firm’s stock in a transaction on Monday, June 3rd. The shares were sold at an average price of $44.07, for a total transaction of $200,298.15. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.90% of the stock is currently owned by company insiders.
Several institutional investors and hedge funds have recently bought and sold shares of the company. Northpointe Capital LLC acquired a new stake in shares of Hologic during the second quarter worth $1,993,000. McGuire Investment Group LLC increased its position in shares of Hologic by 20.6% during the second quarter. McGuire Investment Group LLC now owns 96,190 shares of the medical equipment provider’s stock worth $4,619,000 after buying an additional 16,446 shares during the period. Strs Ohio increased its position in shares of Hologic by 51.0% during the second quarter. Strs Ohio now owns 57,394 shares of the medical equipment provider’s stock worth $2,756,000 after buying an additional 19,378 shares during the period. Hartford Investment Management Co. increased its position in shares of Hologic by 1.0% during the second quarter. Hartford Investment Management Co. now owns 29,736 shares of the medical equipment provider’s stock worth $1,428,000 after buying an additional 291 shares during the period. Finally, Arizona State Retirement System increased its position in shares of Hologic by 23.4% during the second quarter. Arizona State Retirement System now owns 159,375 shares of the medical equipment provider’s stock worth $7,653,000 after buying an additional 30,269 shares during the period. Institutional investors own 96.38% of the company’s stock.
Hologic, Inc, a medical technology company, develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women in the United States, Europe, the Asia-Pacific, and internationally. It operates in five segments: Diagnostics, Breast Health, Medical Aesthetics, GYN Surgical, and Skeletal Health.
Featured Story: Index Funds
Receive News & Ratings for Hologic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hologic and related companies with MarketBeat.com's FREE daily email newsletter.